Stocks and Investing Stocks and Investing
Fri, February 3, 2023
[ 12:00 AM ] - WOPRAI
Krish Sankar Maintained (SYNA) at Buy with Increased Target to $150 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Anthony Stoss Maintained (SYNA) at Strong Buy with Increased Target to $150 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Rolland Maintained (SYNA) at Buy with Increased Target to $145 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Nathan Martin Reiterated (SXC) at Strong Buy and Held Target at $10 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Michael Legg Maintained (SXI) at Strong Buy and Held Target at $150 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
David Macgregor Downgraded (SWK) to Hold on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (SWK) at Hold with Increased Target to $97 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Eric Lau Upgraded (SWK) to Hold and Increased Target to $106 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vivek Juneja Maintained (TFC) at Hold and Held Target at $50 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Rob Owens Maintained (TEAM) at Hold with Increased Target to $160 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (TEAM) at Buy with Decreased Target to $185 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (TEAM) at Strong Buy with Increased Target to $175 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Paul Knight Maintained (TECH) at Buy with Decreased Target to $115 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Puneet Souda Maintained (TECH) at Buy with Decreased Target to $110 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Robert Wasserman Maintained (TECH) at Strong Buy and Held Target at $120 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Raymond Initiated (AGIO) at Buy and Held Target at $41 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Gil Luria Initiated (AI) at Strong Buy and Held Target at $30 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
David Saxon Reiterated (ALC) at Strong Buy and Held Target at $85 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Robert Jones Upgraded (ALGN) to Hold and Held Target at $307 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (AME) at Buy with Increased Target to $155 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (ALL) at Sell with Decreased Target to $104 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Nicole Miller Regan Maintained (ALL) at Buy with Decreased Target to $144 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Emmanuel Rosner Maintained (TSLA) at Strong Buy and Held Target at $220 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (TPR) at Buy with Increased Target to $52 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Carletti Reiterated (THG) at Buy and Held Target at $170 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Daniel Arias Maintained (TMO) at Strong Buy and Held Target at $700 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
David Katz Downgraded (TNL) to Hold and Held Target at $49 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Michael Rollins Maintained (TMUS) at Strong Buy with Increased Target to $176 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Hal Goetsch Downgraded (UPST) to Hold and Held Target at $24 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Biegler Initiated (TYRA) at Buy and Held Target at $17 on, Feb 3rd, 2023

Matthew Biegler Initiated (TYRA) at Buy and Held Target at $17 on, Feb 3rd, 2023


Published on 2024-10-28 01:19:32 - WOPRAI, Matthew Biegler
  Print publication without navigation


Matthew Biegler of Oppenheimer, Initiated "Tyra Biosciences, Inc." (TYRA) at Buy and Held Target at $17 on, Feb 3rd, 2023.

Matthew, nor any peers, have made any analyst calls on TYRA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources